COVID-19 and Inflammatory Bowel Disease: an insight into the relationship between conditions
In December 2019 the now named severe acute respiratory syndrome [...]
New Deal News: publications from IDIBAPS and Inserm
This summer has brought good news for the New Deal [...]
August New Deal Reads
Dining With Inflammatory Bowel Disease: A Review of the Literature [...]
A multidisciplinary look into IBDs: EU research projects overview
Medical sciences have gone far in the last decades. Our [...]
July New Deal Reads
Nanoparticle-Mediated Drug Delivery Systems For The Treatment Of IBD: Current [...]
Tuning a drug: a glimpse into the process of formulation
In every drug, no matter whether it comes as a [...]
June New Deal Reads
The Role of Gut Microbiota Biomodulators on Mucosal Immunity and [...]
May New Deal Reads
Covid-19 and immunomodulation in IBD. Neurath MF, 2020. Gut; 0:1–8. [...]
#MakeIBDwork: some useful tips for workers with IBD and their employers
May the 19th is the World IBD Day: a day [...]
IBD & Tea: A live Twitter debate on the future of inflammatory bowel disease
In the future, patients will receive personalised treatments for inflammatory [...]
